Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Open-market sale Chief Operating Officer sold 181 shares at $138.23 ($25,020)
  2. 4 Open-market sale Chief Commercial Officer sold 657 shares at an average $138.57 ($91,041)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Financial Officer sold 26,624 shares at an average $140.94 ($3,752,286)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 34 shares at $153.13 ($5,206)
  7. 4 Open-market sale Chief Commercial Officer sold 2,063 shares at $148.71 ($306,789)
  8. 4 Open-market sale Director sold 1,000 shares at $152.50 ($152,500)
  9. 4 Open-market sale Chief Development Officer sold 1,041 shares at an average $149.39 ($155,520)
  10. 4 Open-market sale Chief Commercial Officer sold 1,654 shares at $149.43 ($247,157)
  11. 4 Open-market sale Executive Chairman sold 995 shares at $149.38 ($148,631)
  12. 4 Open-market sale Chief Medical Officer sold 464 shares at $150.11 ($69,651)
  13. 4 Open-market sale Chief Medical Officer sold 1,187 shares at an average $154.63 ($183,550)
  14. 4 Grant or award Chief Science Officer acquired 113 shares (grant or award)
  15. 4 Grant or award Chief Development Officer acquired 154 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 100 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 66 shares (grant or award)
  18. 4 Grant or award Chief Medical Officer acquired 90 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 118 shares (grant or award)
  20. 4 Grant or award Chief Commercial Officer acquired 154 shares (grant or award)

Page 14 of 39 · 780 filings